dijous, 9 d’octubre del 2014

UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device




An FDA advisory panel's unprecedented 3rd hearing over Boston Scientific's Watchman anti-stroke device barely favors the cardiac implant.





UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device

Boston Scientific, Food & Drug Administration (FDA)

News Well, Cardiac Implants, Regulatory/Compliance, Stroke, Wall Street Beat

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xtm3hS
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)